Carole Lyn Zeleny

Director of Investor Relations



Ms. Zeleny has extensive experience in the biotech field and has held positions at Sanford Burnham Prebys Medical Discovery Institute, Illumina Inc., and Johnson & Johnson Pharmaceutical Services, LLC.  Carole Lyn is responsible for ensuring the company is appropriately and strategically positioned with investors, and all stakeholders.  She is responsible for creating the appropriate strategy, framework, and tactics, as well as for providing a compelling investor relations roadmap.  Ms. Zeleny joined Allele Biotechnology in 2017 and received her B.B.A. in International Business from Ohio University. Back->